Bain Capital Life Sciences Investors

Latest statistics and disclosures from Bain Capital Life Sciences Investors's latest quarterly 13F-HR filing:

Portfolio Holdings for Bain Capital Life Sciences Investors

Companies in the Bain Capital Life Sciences Investors portfolio as of the March 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Springworks Therapeutics Inc 33.25 7.28M 27.00
Arcutis Biotherapeutics 20.05 3.98M NEW 29.80
Dicerna Pharmaceuticals 12.68 4.08M 18.37
Constellation Pharmceticls I 11.71 2.20M -21% 31.43
Dynavax Technologies 5.21 8.73M +3% 3.53
Replimune Group Inc 4.79 2.84M 9.97
Savara 3.89 5.13M 4.48
X4 Pharmaceuticals Inc 2.79 1.65M 10.00
Marinus Pharmaceuticals 2.04 5.94M 2.03
Aptinyx Inc 2.03 5.56M +149% 2.16
Solid Biosciences 1.56 3.87M 2.39

Past Filings by Bain Capital Life Sciences Investors

View past SEC 13F filings by Bain Capital Life Sciences Investors

View all filings